Research and Markets: Global Preventive Asthma Drugs Market 2011-2015 Report: AstraZeneca, GSK, Merck and Novartis AG Dominate the Industry

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4cb7jq/global_preventive) has announced the addition of the "Global Preventive Asthma Drugs Market 2011-2015" report to their offering.

TechNavio's analysts forecast the Global Preventive Asthma Drugs market to grow at a CAGR of 4.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing incidence of asthma. The Global Preventive Asthma Drugs market has also been witnessing the trend of an increased focus on contract manufacturing outsourcing. However, the increasing generic competition could pose a challenge to the growth of this market.

TechNavio's report, the Global Preventive Asthma Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preventive Asthma Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are AstraZeneca plc., GlaxoSmithKline plc., Merck & Co.Inc., Novartis AG

Key questions answered in this report:

What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

04.1 Global Preventive Asthma Drugs Market

04.2 Global Preventive Asthma Drugs Market by Product Segmentation

04.3 Five Forces Analysis

05. Geographical Segmentation

06. Rate of Incidence and Prevalence

07. Vendor Landscape

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/4cb7jq/global_preventive

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Recent Stories

Research and Markets: Quarterly Overall Retail Growth: Q1 2013 - Sales and volume growth trends in 35 European countries and regions ( Subscription - 4 Quarterly Reports)

June 20, 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rhfbdj/quarterly_overall) has announced the addition of the "Quarterly Overall Retail Growth: Q1 2013 - Sal... more »
Research and Markets: Global Acidity Regulators Market -2013 Report

June 20, 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/r8hpsl/acidity) has announced the addition of the "Acidity Regulators Market By Type (Acetic Acid, Citric A... more »
Research and Markets: Russian Sauces and the Industry Market - 2013 Report

June 20, 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tk8c4g/russian_sauces) has announced the addition of the "Russian Sauces and the Industry Market - 2013 Rep... more »